Acute promyelocytic leukemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Acute promyelocytic leukemia is relatively rare compared to other diseases. It predominantly affects people of Latin American descent and least commonly affects African Americans. It is more common in older adults.
Acute promyelocytic leukemia is relatively rare compared to other [[Disease|diseases]]. It predominantly affects people of Latin American descent and least commonly affects African Americans. It is more common in older [[Adult|adults]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 18:36, 15 January 2019

Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia epidemiology and demographics

CDC on Acute promyelocytic leukemia epidemiology and demographics

Acute promyelocytic leukemia epidemiology and demographics in the news

Blogs on Acute promyelocytic leukemia epidemiology and demographics

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

Acute promyelocytic leukemia is relatively rare compared to other diseases. It predominantly affects people of Latin American descent and least commonly affects African Americans. It is more common in older adults.

Epidemiology and Demographics

  • The incidence of acute promyelocytic leukemia is 0.2 to 0.26 per 100,000 annually in the United States, which corresponds to 600-800 cases of acute promyelocytic leukemia per year.[1]
  • Acute promyelocytic leukemia affects approximately 1,500 people per year in the United States.[2]
  • Caucasians are more commonly affected by acute promyelocytic leukemia than African Americans.[1] The incidence in Caucasians is 0.18 per 100,000. The incidence is African Americans is 0.14 per 100,000.[1]
  • Asians and Pacific islanders are more commonly affected by acute promyelocytic leukemia than African Americans.[1]
  • The incidence is higher in people of Latin American descent compared to Caucasian descent.[1]
  • Men are more commonly affected by acute promyelocytic leukemia than women. The incidence in men is 0.19 per 100,000, and the incidence in women is 0.17 per year.[1]
  • Older patients are more likely to develop acute promyelocytic leukemia than younger patients. The incidence of acute promyelocytic leukemia in people above age 60 is 0.36 per 100,000. The incidence in people under age 20 is 0.06 per 100,000.
  • Acute promyelocytic leukemia represents 10-15%% of all cases of acute myeloid leukemia in adults.[3] The median age is approximately 40 years, which is considerably younger than the other subtypes of acute myeloid leukemia (70 years).
  • The incidence of acute promyelocytic leukemia has increased over time from 1975-2008.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Chen Y, Kantarjian H, Wang H, Cortes J, Ravandi F (2012). "Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008". Cancer. 118 (23): 5811–8. doi:10.1002/cncr.27623. PMC 4180246. PMID 22707337.
  2. Kumar S, Yedjou CG, Tchounwou PB (2014). "Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells". J Exp Clin Cancer Res. 33: 42. doi:10.1186/1756-9966-33-42. PMC 4049373. PMID 24887205.
  3. Chen C, Huang X, Wang K, Chen K, Gao D, Qian S (2018). "Early mortality in acute promyelocytic leukemia: Potential predictors". Oncol Lett. 15 (4): 4061–4069. doi:10.3892/ol.2018.7854. PMC 5835847. PMID 29541170.

Template:WH Template:WS